EU regulators clear IMS Health sale to TPG

BRUSSELS, Feb 3 (BestGrowthStock) – Private equity firm TPG [TPG.UL]
and the Canada Pension Plan gained European Union regulatory
approval on Wednesday for their $4 billion buyout of
prescription drug sales data provider IMS Health Inc (RX.N: ).

The deal, announced by the companies last November, was the
biggest leveraged buyout up to that period in 2009, excluding
debt, and underlined improved optimism in the merger market.

The European Commission said the transaction would not
impede competition in the European Economic Area.

“There are no horizontal overlaps between the parties’
activities,” the EU competition watchdog said in a statement.

The IMS deal followed other acquisitions in the wider
healthcare and pharmaceuticals industry such as Wyeth’s $68
billion merger with Pfizer (PFE.N: ).

Stock Analysis

(Reporting by Foo Yun Chee, editing by Timothy Heritage)

EU regulators clear IMS Health sale to TPG